{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:03:04Z","timestamp":1780354984185,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Acute retinal necrosis is considered a rare infectious uveitis. This condition is usually caused by varicella-zoster virus or herpes simplex virus. Acute retinal necrosis caused by co-infection with multiple viruses is extremely rare. Herein, we report a case of acute retinal necrosis caused by co-infection with herpes simplex virus (type I and II) and varicella-zoster virus (VZV) in a natalizumab-treated patient due to multiple sclerosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>An adult man presented with a complaint of decreased vision of the right eye from 12 days ago. He was a known case of multiple sclerosis receiving natalizumab. Examination of the right eye revealed severe conjunctival injection, fine diffuse keratic precipitates, 3\u2009+\u2009anterior chamber and vitreous cells, elevated intraocular pressure (26 mmHg), a blurred optic disk with hemorrhagic patches, and occlusive vasculitis plus confluent necrotizing patches in the peripheral retina compatible with diagnosis of acute retinal necrosis. He underwent anterior chamber and vitreous tap, and real-time PCR detected HSV I &amp; II and VZV on the vitreous specimen. A second PCR showed the same result. After neurological consultation, natalizumab was discontinued and intravenous acyclovir was started followed by oral acyclovir and oral prednisolone to control the disease, which was successful.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Although rare, multiple-viral infection should be considered in the physiopathology of acute retinal necrosis, especially in immunosuppressed patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-021-02096-x","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T13:04:06Z","timestamp":1631797446000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Acute retinal necrosis caused by co-infection with multiple viruses in a natalizumab-treated patient: a case report and brief review of literature"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1273-9166","authenticated-orcid":false,"given":"Kasra","family":"Cheraqpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliasghar","family":"Ahmadraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rashidinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maziyar","family":"Irannejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoor","family":"Shahriari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"issue":"1","key":"2096_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12348-015-0068-6","volume":"6","author":"AB Sood","year":"2016","unstructured":"Sood AB, Kumar G, Robinson J. Bilateral acute retinal necrosis in a patient with multiple sclerosis on natalizumab. J Ophthalm Inflamm Infect. 2016;6(1):1\u20134.","journal-title":"J Ophthalm Inflamm Infect"},{"issue":"11","key":"2096_CR2","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1136\/bjo.2007.114884","volume":"91","author":"MN Muthiah","year":"2007","unstructured":"Muthiah MN, Michaelides M, Child C, Mitchell SM. Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK. Br J Ophthalmol. 2007;91(11):1452\u20135.","journal-title":"Br J Ophthalmol"},{"key":"2096_CR3","doi-asserted-by":"crossref","unstructured":"Cruz GP, Fonseca C, Oliveira J, Saraiva da Cunha J. Acute retinal necrosis by herpes simplex virus type 1: an unusual presentation of a primary infection. BMJ Case Rep. 2019;12(12):e232566.","DOI":"10.1136\/bcr-2019-232566"},{"key":"2096_CR4","doi-asserted-by":"crossref","unstructured":"Chan EW, Sun V, Eldeeb M, Kapusta MA. Epstein\u2013barr virus acute retinal necrosis in an immunocompetent host. Retin Cases Brief Rep. 2021;15(4):412\u20136.","DOI":"10.1097\/ICB.0000000000000819"},{"issue":"5","key":"2096_CR5","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/09273948.2019.1624780","volume":"28","author":"HB \u00d6zdemir","year":"2020","unstructured":"\u00d6zdemir HB, \u00d6zdal P. Human adenovirus: an unusual causative agent for acute retinal necrosis presented with central retinal vascular occlusion. Ocul Immunol Inflamm. 2020;28(5):749\u201353.","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"2096_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/00055735-200106000-00008","volume":"12","author":"G Walters","year":"2001","unstructured":"Walters G, James TE. Viral causes of the acute retinal necrosis syndrome. Curr Opin Ophthalmol. 2001;12(3):191\u20135.","journal-title":"Curr Opin Ophthalmol"},{"key":"2096_CR7","doi-asserted-by":"crossref","unstructured":"Bonfioli AA, Eller AW. Acute retinal necrosis. In: Semin Ophthalmol. Taylor & Francis; 2005. pp.\u00a0155\u201360.","DOI":"10.1080\/08820530500232027"},{"issue":"9","key":"2096_CR8","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.3174\/ajnr.A2226","volume":"31","author":"D Selewski","year":"2010","unstructured":"Selewski D, Shah G, Segal B, Rajdev P, Mukherji S. Natalizumab (Tysabri). Am J Neuroradiol. 2010;31(9):1588\u201390.","journal-title":"Am J Neuroradiol"},{"issue":"6","key":"2096_CR9","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/cid\/cit376","volume":"57","author":"AJ Fine","year":"2013","unstructured":"Fine AJ, Sorbello A, Kortepeter C, Scarazzini L. Central nervous system herpes simplex and varicella zoster virus infections in natalizumab-treated patients. Clin Infect Dis. 2013;57(6):849\u201352.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2096_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-11-19","volume":"11","author":"X Kobeleva","year":"2014","unstructured":"Kobeleva X, Wegner F, Brunotte I, Dadak M, Dengler R, Stangel M. Varicella zoster-associated retinal and central nervous system vasculitis in a patient with multiple sclerosis treated with natalizumab. J Neuroinflamm. 2014;11(1):1\u20134.","journal-title":"J Neuroinflamm"},{"key":"2096_CR11","doi-asserted-by":"crossref","unstructured":"Pawlitzki M, Teuber J, Campe C, Wagner M, Schuart C, Paul F, Bittner D. VZV-associated acute retinal necrosis in a patient with MS treated with natalizumab. Neurol Neuroimmunol Neuroinflamm. 2018;5(5):e475.","DOI":"10.1212\/NXI.0000000000000475"},{"issue":"3","key":"2096_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/ICB.0000000000000136","volume":"9","author":"VS Saraiva","year":"2015","unstructured":"Saraiva VS. Acute retinal necrosis and immune reconstitution inflammatory syndrome in a natalizumab-treated patient with multiple sclerosis. Retin Cases Brief Rep. 2015;9(3):195\u20137.","journal-title":"Retin Cases Brief Rep"},{"issue":"21","key":"2096_CR13","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1212\/WNL.0000000000001611","volume":"84","author":"SH Van Tassel","year":"2015","unstructured":"Van Tassel SH, Gupta MP, Orlin A, Nealon NM, Patel SS. Progressive outer retinal necrosis in a multiple sclerosis patient on natalizumab. Neurology. 2015;84(21):2198\u20139.","journal-title":"Neurology"},{"key":"2096_CR14","doi-asserted-by":"publisher","first-page":"102838","DOI":"10.1016\/j.msard.2021.102838","volume":"50","author":"ZL van Kempen","year":"2021","unstructured":"van Kempen ZL, van Rossum JA, Hoogervorst E, Strijbis E, Toorop A, Bosscha MI, Frequin S, Ten Dam-van Loon N, Wattjes MP, Murk J-L. Varicella zoster-associated acute retinal necrosis and central nervous system complications in natalizumab treated MS patients. Mult Scler Relat Disord. 2021;50:102838.","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"2096_CR15","doi-asserted-by":"publisher","first-page":"e229137","DOI":"10.1136\/bcr-2018-229137","volume":"12","author":"T Kobayashi","year":"2019","unstructured":"Kobayashi T, Sekar P, Meier J, Streit J. Acute retinal necrosis in a patient with remote severe herpes simplex encephalitis. BMJ Case Rep. 2019;12(5):e229137.","journal-title":"BMJ Case Rep"},{"key":"2096_CR16","doi-asserted-by":"crossref","unstructured":"Chen S, Malik KJ, Shen D, Chan C-C. Acute retinal necrosis with multiple viral infections: a case report. Int J Ophthalm Pathol. 2014;3(5).","DOI":"10.4172\/2324-8599.1000151"},{"key":"2096_CR17","first-page":"853","volume":"9","author":"T Nakamura","year":"2015","unstructured":"Nakamura T, Daikoku T, Shiraki K, Hayashi A. Detection of cytomegalovirus in an immunocompetent adult presenting with acute retinal necrosis due to varicella-zoster virus: a case report. Clin Ophthalmol. 2015;9:853.","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"2096_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1128\/CMR.19.1.165-256.2006","volume":"19","author":"M Espy","year":"2006","unstructured":"Espy M, Uhl J, Sloan L, Buckwalter S, Jones M, Vetter E, Yao J, Wengenack N, Rosenblatt J, Cockerill F III. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev. 2006;19(1):165\u2013256.","journal-title":"Clin Microbiol Rev"},{"key":"2096_CR19","first-page":"14","volume":"2020","author":"B Powell","year":"1931","unstructured":"Powell B, Wang D, Llop S, Rosen RB. Management strategies of acute retinal necrosis: current perspectives. Clin Ophthalmol. 1931;2020:14.","journal-title":"Clin Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02096-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-021-02096-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02096-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T13:11:04Z","timestamp":1631797864000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-021-02096-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2096"],"URL":"https:\/\/doi.org\/10.1186\/s12886-021-02096-x","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,16]]},"assertion":[{"value":"2 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the tenets of the Declaration of Helsinki. Ethics committee approval was not required for this case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We obtained written consent to publish from the patient for publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflicts of interest.\u00a0Please provide the ORCID of author Kasra Cheraqpour;\u00a0.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"337"}}